Stay updated on Apremilast in Nummular Eczema Clinical Trial

Sign up to get notified when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apremilast in Nummular Eczema Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, signaling a new page revision of the study record.
    Difference
    0.1%
    Check dated 2026-05-15T06:51:50.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A minor update to the site’s revision/version identifier is reflected in the interface (from v3.5.2 to v3.5.3). This does not change the underlying study record details.
    Difference
    0.1%
    Check dated 2026-04-24T05:53:52.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This change does not modify trial data or publicly visible details.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:50.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.5.0 updated from v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-19T04:56:10.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3; the previous revision tag v3.4.2 is no longer shown.
    Difference
    0.1%
    Check dated 2026-03-12T02:24:34.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Site revision updated to v3.4.2. The prior revision notice (v3.4.1) and the funding/status notice were removed.
    Difference
    0.5%
    Check dated 2026-02-11T11:57:37.000Z thumbnail image

Stay in the know with updates to Apremilast in Nummular Eczema Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.